Roadzen Inc. — SEC filing summary
Filing identity and period: This is Vahanna Tech Edge Acquisition I Corp.’s unaudited Form 10-Q for the quarter ended March 31, 2023, signed May 19, 2023. Vahanna was a SPAC pursuing a merger with Roadzen; these financial statements are for the SPAC, not Roadzen’s operating business.
Business context and proposed combination
Vahanna had not commenced operations or generated operating revenue. On February 10, 2023, it agreed to merge with Roadzen, with Roadzen to become a wholly owned subsidiary and the combined company to be named Roadzen Inc. The agreement provided for 68.3 million shares for Roadzen equityholders on a fully diluted basis, including shares reserved for assumed equity awards and warrants. Closing was expected in Q2 2023, subject to approvals and other conditions.
Key deal conditions included at least $50 million of funds available after redemptions and specified financing, completion of Roadzen’s agreed acquisitions of Global Insurance Management Limited and National Automobile Club, shareholder and regulatory approvals, and Nasdaq listing. The agreement also included a redemption-related condition for domestication: fewer than 12 million Class A shares must have elected redemption by the specified deadline. The filing reports the merger could be terminated if not completed by August 26, 2023, subject to specified extensions.
Financial results and position
| Metric | Three months ended March 31, 2023 | Prior comparable period |
|---|---|---|
| Operating revenue | None | None |
| General and administrative expense | $2.053 million | $0.209 million |
| Total expenses, including related-party administration fee | $2.113 million | $0.269 million |
| Trust investment gains and other investment income | $2.204 million | $0.106 million |
| Net income (loss) | $0.091 million | $(0.163) million |
| Basic and diluted earnings (loss) per share | $0.00 | $(0.01) |
| Net cash used in operating activities | $(0.552) million | $(0.645) million |
At March 31, 2023, Vahanna reported cash of $174,419, prepaid expenses of $90,748, and $209.296 million of Trust Account investments. Current liabilities were $3.610 million, including a $975,000 related-party convertible note and $2.635 million of accrued expenses. It also reported a $6.525 million deferred underwriting fee contingent on completing a business combination, redeemable Class A shares of $209.296 million, and shareholders’ deficit of $9.869 million. No revenue-based margins are meaningful for this non-operating SPAC.
Cash increased by $123,456 during the quarter: $551,544 of operating cash use was more than offset by $675,000 of proceeds from the related-party convertible note. The note balance rose from $300,000 at December 31, 2022. The filing reports no long-term debt or off-balance-sheet financing arrangements.
Changes, outlook, risks, and unusual items
- General and administrative expense increased substantially year over year, while trust investment gains rose to $2.204 million and moved results from a loss to modest net income. Net income therefore reflected trust returns, not operating activity.
- Management stated it expected available resources to cover needs through a business combination or the applicable deadline, but disclosed substantial doubt about the company’s ability to continue as a going concern for at least one year from issuance, given limited working capital and mandatory liquidation if no combination occurs. Sponsor and insider loans were possible but not committed.
- The original 18-month combination deadline was May 26, 2023, with up to three one-month extensions under the then-current governing documents. After quarter-end, the Sponsor requested the first one-month extension to June 26, 2023 and indicated it intended to deposit $660,330 into the Trust Account. A separate proposed amendment described in the filing would allow up to twelve monthly extensions and change trust investments to cash in an interest-bearing account; approval was not established in this filing.
- The transaction carried material execution and financing risks, including shareholder redemptions, the $50 million minimum-funds condition, required approvals and acquisitions, and potential need for additional financing. Failure to complete a combination by the applicable deadline would require liquidation; warrants could expire worthless.
- Transaction-related fees included a $6.525 million deferred underwriting commission and stated success/advisory fees of $2.5 million each for Mizuho and Marco Polo, payable upon completion, plus expense reimbursements where applicable.
- The filing contains an apparent Trust Account value inconsistency: the balance sheet and related notes report $209,296,150 at March 31, while the fair-value table reports $209,596,150. Verify the correct amount against the filed financial statements.
- Management concluded disclosure controls and procedures were effective as of March 31, 2023 and reported no material quarterly change in internal control over financial reporting. No legal proceedings were reported; the filing stated there were no material changes to previously disclosed risk factors.
Important facts for investors to verify
- Whether the Roadzen merger closed, and its final terms, approvals, financing, redemption levels, and satisfaction of the $50 million funds condition.
- The Trust Account balance and the apparent $300,000 discrepancy between the balance sheet and fair-value table.
- Whether the extension and proposed charter/trust amendments were approved, and the resulting combination deadline and required Sponsor deposits.
- Roadzen’s own operating results, cash position, debt, acquisition status, and fully diluted capitalization; they are not presented in this SPAC’s quarterly financial statements.
- The final transaction costs, dilution, and fees payable at closing, including treatment of the deferred underwriting commission and advisory/success fees.